Neuroscience

Investigational drug may reduce involuntary movements

Results of the first randomized, placebo-controlled long-term clinical trial show the investigational drug safinamide may reduce dyskinesia or involuntary movements in mid-to-late stage Parkinson's disease. The findings will ...

Medications

Pfizer disputes suit claiming Zoloft doesn't work

(AP)—The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill. The federal lawsuit, filed in California, argues that patients who took it should be reimbursed ...

Oncology & Cancer

Hypnosis helps hot flashes

Hypnosis can help cut hot flashes by as much as 74%, shows a study supported by the National Center for Complementary and Alternative Medicine. This is the first controlled, randomized study of the technique to manage hot ...

page 5 from 5